TALPHERA, INC. — Director's Dealing 2017

Apr 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2017-04-10

Reporting Person: Hamel Lawrence G (Chief Development Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-10	Common Stock	A	9122	$1.20	Acquired	73475	Direct
2017-04-10	Common Stock	A	6879	—	Acquired	80354	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-04-10	Stock Option (Right to Buy)	$1.20	D	9122	Disposed	2017-12-05	Common Stock (9122)	Direct

Footnotes

F1: Non-reportable acquisition of 6,879 shares of Common Stock through the Company's Employee Stock Purchase Plan.

F2: Options vest as follows: 1/4 of the shares subject to the option vest on December 4, 2008 with the remaining shares subject to the option vesting on an equal monthly basis over 36 months.